Literature DB >> 22776677

Severity of anxiety and depression are related to a higher perception of adverse effects of antiepileptic drugs.

Bety Gómez-Arias1, Daniel Crail-Meléndez, Rosario López-Zapata, Iris E Martínez-Juárez.   

Abstract

UNLABELLED: After reviewing the negative effects of antiepileptic drugs (AEDs) on general health and quality of life, the Commission on Outcome Measurement from the International League Against Epilepsy (ILAE) recommended incorporating reliable and valid tools in clinical essays in order to achieve a more accurate assessment of the subjective adverse effects rate and disease severity when using AEDs.
PURPOSE: The aim of this study was to correlate the severity of adverse effects of AEDs, with the presence of anxiety and depression in patients with epilepsy.
METHODS: The Spanish version of the Liverpool Adverse Events Profile (LAEP) and the hospital anxiety and depression scale (HADS) were applied on 130 consecutive outpatients with epilepsy from the epilepsy clinic at the Mexico's National Institute of Neurology and Neurosurgery. A correlation analysis was carried out to determine if the presence of depression and anxiety was related to the adverse effects of AEDs. The relation between LAEP scores with other epidemiological variables was also assessed.
RESULTS: Our study found a positive correlation between the LAEP and the HADS scores (p < or = 0.01). The most common adverse effects were drowsiness (81.5% [n=106]), difficulty in concentrating (76% [n=99]), and nervousness and/or agitation (75% [n=97]). Female gender, a history of febrile seizures, persistent seizures and polytherapy were associated with a higher toxicity on LAEP. In our study, age at epilepsy onset, duration of epilepsy, type of epilepsy and patients' age were not related to higher LAEP scores.
CONCLUSION: Adverse effects to AEDs can be related with the presence of psychiatric disorders such as anxiety and depression in patients with epilepsy.
Copyright © 2012 British Epilepsy Association. Published by Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22776677     DOI: 10.1016/j.seizure.2012.06.003

Source DB:  PubMed          Journal:  Seizure        ISSN: 1059-1311            Impact factor:   3.184


  12 in total

Review 1.  Anxiety and epilepsy: what neurologists and epileptologists should know.

Authors:  Heidi M Munger Clary
Journal:  Curr Neurol Neurosci Rep       Date:  2014-05       Impact factor: 5.081

2.  Baseline psychiatric evaluations are needed to treat seizures.

Authors:  Rochelle Caplan
Journal:  Epilepsy Curr       Date:  2012-11       Impact factor: 7.500

3.  Increased Expression of Brain-Derived Neurotrophic Factor Transcripts I and VI, cAMP Response Element Binding, and Glucocorticoid Receptor in the Cortex of Patients with Temporal Lobe Epilepsy.

Authors:  G A Martínez-Levy; L Rocha; F Rodríguez-Pineda; M A Alonso-Vanegas; A Nani; R M Buentello-García; M Briones-Velasco; D San-Juan; J Cienfuegos; C S Cruz-Fuentes
Journal:  Mol Neurobiol       Date:  2017-05-19       Impact factor: 5.590

4.  Affective symptoms and determinants of health-related quality of life in Mexican people with epilepsy.

Authors:  Carlos R Camara-Lemarroy; Mariana Hoyos; Beatriz E Ibarra-Yruegas; Marco A Díaz-Torres; Rolando De León
Journal:  Neurol Sci       Date:  2017-07-25       Impact factor: 3.307

5.  GABAergic alterations in neocortex of patients with pharmacoresistant temporal lobe epilepsy can explain the comorbidity of anxiety and depression: the potential impact of clinical factors.

Authors:  Luisa Rocha; Mario Alonso-Vanegas; Iris E Martínez-Juárez; Sandra Orozco-Suárez; David Escalante-Santiago; Iris Angélica Feria-Romero; Cecilia Zavala-Tecuapetla; José Miguel Cisneros-Franco; Ricardo Masao Buentello-García; Jesús Cienfuegos
Journal:  Front Cell Neurosci       Date:  2015-01-05       Impact factor: 5.505

6.  Impact of a pharmaceutical care programme on health-related quality of life among women with epilepsy: a randomised controlled trial (IPHIWWE study).

Authors:  Martha Losada-Camacho; Mario F Guerrero-Pabon; Pilar Garcia-Delgado; Fernando Martínez-Martinez
Journal:  Health Qual Life Outcomes       Date:  2014-10-31       Impact factor: 3.186

7.  Endocannabinoid System and Cannabinoid 1 Receptors in Patients With Pharmacoresistant Temporal Lobe Epilepsy and Comorbid Mood Disorders.

Authors:  Luisa Rocha; Resat Cinar; Rosalinda Guevara-Guzmán; Mario Alonso-Vanegas; Daniel San-Juan; Iris Martínez-Juárez; José Luis Castañeda-Cabral; Francia Carmona-Cruz
Journal:  Front Behav Neurosci       Date:  2020-05-06       Impact factor: 3.558

8.  Anti-epileptic effects of neuropeptide Y gene transfection into the rat brain.

Authors:  Changzheng Dong; Wenqing Zhao; Wenling Li; Peiyuan Lv; Xiufang Dong
Journal:  Neural Regen Res       Date:  2013-05-15       Impact factor: 5.135

9.  Association between Adverse Effects and Parental Beliefs about Antiepileptic Medicines.

Authors:  Violeta Ilić; Dragana Bogićević; Branislava Miljković; Sandra Vezmar-Kovačević
Journal:  Medicina (Kaunas)       Date:  2018-08-28       Impact factor: 2.430

10.  Temporal Profiles and Dose-Responsiveness of Side Effects with Escitalopram and Duloxetine in Treatment-Naïve Depressed Adults.

Authors:  Philip E Polychroniou; Helen S Mayberg; W Edward Craighead; Jeffrey J Rakofsky; Vivianne Aponte Rivera; Ebrahim Haroon; Boadie W Dunlop
Journal:  Behav Sci (Basel)       Date:  2018-07-17
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.